Editorial
Major technological advances often lead to significant scientific breakthroughs. Over the past decade, many new technologies have emerged; among them, two, i.e., next-generation sequencing and genome-editing, may have had the greatest impact on biomedical research.
After 30 years of dominance, Sanger sequencing was finally replaced by deep, high-throughput, in-parallel deoxyribonucleic acid (DNA) sequencing technologies, also called next-generation sequencing. Next-generation sequencing has made the genome-wide detection of DNA and ribonucleic acid (RNA) sequences and their chemical modifications efficiently and economically. Consequently, significant progress has been made in the identification of gene mutations responsible for many diseases. Moreover, new insights into gene regulation at transcriptional, post-transcriptional, translational, and post-translational levels have been gained over the past decade. As a further development of deep-sequencing technologies, single-cell RNA deep sequencing, which combines microfluidics with singlecell transcriptomic analyses, represents one of the latest technological advances. By transcriptomic profiling of single cells, new cell types or subtypes have been discovered, and the complicated spatiotemporal regulation of gene expression during development and specific physiological processes has begun to be uncovered.
Since its initial appearance in 2012, CRISPR/Cas-based genome editing has quickly become the most widely used technology for efficient and precise manipulation of the genome. As a result, the speed at which the physiological roles of hundreds of thousands of genes are defined through animal models has been drastically accelerated. With continuous improvement, this technology not only has become a standard tool for almost all laboratory studies, but also bears the hope for finding cures for many genetic diseases.
Benefiting from these new technologies, the field of reproductive biology has also witnessed a significant progress over the past ∼10 years. To highlight new horizons in our field, we are publishing a special issue. A number of our best investigators have accepted our invitation and contributed comprehensive reviews on topics of significant progress, including artificial spermatid-based genome editing (Jinsong Li), in vitro differentiation of sperm (Katsuhiko Hayashi), sexual differentiation of the reproductive tracts (Humphrey Yao), maternal-fetal interactions (Peter J. Hansen), spermatogenesis (Jeremy Wang), maternal-to-zygotic transition (Heng-Yu Fan), female infertility (Svetlana A. Yatsenko and Aleksandar Rajkovic), epigenetic effects of environmental exposures on female reproduction (Jodi Flaws), single-cell RNA-seq of spermatogenic cells (Brian Hermann), ovarian cancer (David P. Cook and Barbara C. Vanderhyden), and reproduction of rare and endangered species (Pierre Comizzoli). Although we could not cover every area in this special issue, we hope that you find these views of the future representative of our fast-developing field, which has never been this exciting and inspiring. Happy reading!
